Arbutus Biopharma Corporation Common Stock
Symbol: ABUS (NASDAQ)
4.93
▲ (6.80%) 0.314
Company Description:
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Key Stats
- Today's Open: $4.65
- Today's High: $5.095
- Today's Low: $4.558
- Today's Volume: 5.05M
- Yesterday Close: $4.62
- Yesterday High: $4.69
- Yesterday Low: $4.39
- Yesterday Volume: 2.61M
- Last Min Volume: 0
- Last Min High: $4.934
- Last Min Low: $4.927
- Last Min VWAP: $0
Company Profile
- Name: Arbutus Biopharma Corporation Common Stock
- Website: http://www.arbutusbio.com
- Listed Date: 2007-07-26
- Location: WARMINSTER, PA
- Market Status: Active
- CIK Number: 0001447028
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $885.65M
- Round Lot: 100
- Outstanding Shares: 191.70M
- Asset Type: CS
RECENT FILINGS FOR ABUS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 3 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-06-25 | 8-K | View |
| 2025-05-23 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-05-07 | 8-K | View |
| 2025-04-23 | 8-K | View |
| 2025-04-21 | 144 | View |
| 2025-04-15 | 144 | View |
| 2025-04-04 | DEFA14A | View |
| 2025-04-04 | DEF 14A | View |
| 2025-04-03 | 8-K | View |
| 2025-04-01 | 4/A | View |
| 2025-03-31 | 4 | View |
| 2025-03-31 | 3 | View |
Latest News on ABUS